Copeptin After Arginine Infusion in Polyuria-Polydipsia Syndrome

Completed

• Conditions: Polyuria-polydipsia Syndrome; Healthy

• Registration Number: NCT01879137
• Lead Sponsor: University Hospital, Basel, Switzerland

Brief Summary

the purpose of the study is to investigate whether arginine infusion is a new tool to differentiate patients with diabetes insipidus, primary polydipsia and healthy subjects.

Detailed Description

Not available

Study Timeline

• Study Start: 2013-06
• Study First Submitted: 2013-06-12
• Study First Submitted QC: 2013-06-14
• Study First Posted: 2013-06-17
• Primary Completion: 2017-05
• Study Completion: 2017-05
• Status Verified: 2017-07
• Last Update Submitted: 2017-07-10
• Last Update Posted: 2017-07-11

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

1. Age over 18 years
2. No medication except hormonal contraception

Exclusion Criteria

1. Evidence of any acute illness
2. Subjects refusing or unable to give written informed consent
3. Pregnancy
4. Any evidence of disordered drinking habits and diuresis

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Discriminative value of copeptin after arginine infusion in the differential diagnosis of polyuria-polydipsia syndrome.	up to 120 minutes after the Arginine infusion.

Trial Locations

Locations (1)

University Hospital Basel; 🇨🇭 Basel, Basel-Stadt, Switzerland